📰 Repligen Co News
Page 5 - Repligen Co News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Repligen Co. Real-time updates on events, politics, business and more.
September 1, 2023
Repligen Co. (NASDAQ:RGEN – Get Free Report) Director Karen A. Dawes sold 850 shares of the firm’s stock in a transaction dated Tuesday, August 29th. The stock was sold at an average price of $171.38, for a total value of $145,673.00. Following the transaction, the director now directly owns 83,741 shares in the company, valued […]
August 27, 2023
Skandinaviska Enskilda Banken AB publ lowered its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 1.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,556 shares of the biotechnology company’s stock after selling 123 shares during […]
August 22, 2023
Swiss National Bank lessened its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 2.4% in the 1st quarter, HoldingsChannel.com reports. The firm owned 208,900 shares of the biotechnology company’s stock after selling 5,200 shares during the period. Swiss National Bank’s holdings in Repligen were worth $35,170,000 as of its most recent filing […]
August 18, 2023
Bessemer Group Inc. lifted its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 1.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 285,114 shares of the biotechnology company’s stock after acquiring an additional 4,098 shares during the […]
August 11, 2023
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
August 8, 2023
Federated Hermes Inc. reduced its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 11.0% in the first quarter, according to its most recent filing with the SEC. The fund owned 450,661 shares of the biotechnology company’s stock after selling 55,746 shares during the period. Federated Hermes Inc. owned approximately 0.81% of Repligen […]
August 3, 2023
Repligen Co. (NASDAQ:RGEN – Get Free Report) shares shot up 5.9% on Wednesday . The stock traded as high as $181.26 and last traded at $177.01. 436,487 shares traded hands during mid-day trading, a decline of 26% from the average session volume of 590,124 shares. The stock had previously closed at $167.12. Analysts Set New […]
July 26, 2023
Repligen Co. (NASDAQ:RGEN – Free Report) – Equities researchers at SVB Leerink dropped their Q2 2023 EPS estimates for Repligen in a note issued to investors on Friday, July 21st. SVB Leerink analyst P. Souda now expects that the biotechnology company will post earnings per share of $0.44 for the quarter, down from their previous […]
July 24, 2023
Pembroke Management LTD reduced its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 7.4% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 37,437 shares of the biotechnology company’s stock after selling 2,983 shares during the period. Pembroke Management […]
July 21, 2023
Virtu Financial LLC acquired a new stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 4,780 shares of the biotechnology company’s stock, valued at approximately $805,000. Other institutional investors also recently added to or reduced […]